학술논문
PYRROLIDINES AS NK3 RECEPTOR ANTAGONISTS
Document Type
Patent
Author
Source
Subject
Language
Abstract
The present invention relates to a compounds of formula I [chemical expression included] wherein R1, R2, Ar1, Ar2, R′, R″, m, n, and o are defined in the specification or to a pharmaceutically active salt, racemic mixture, enantiomer, optical isomer or to tautomeric form thereof. The present compounds are high potential NK-3 receptor antagonists for the treatment of depression, pain, psychosis, Parkinson's disease, schizophrenia, anxiety and attention deficit hyperactivity disorder (ADHD).